DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Building BlocksBuilding Blocks
  4. /Heterocyclic ScaffoldsHeterocyclic Scaffolds
  5. /IndolesIndoles
  6. /PROTAC VHL-type degrader-1PROTAC VHL-type degrader-1
Chemical structure of CAS 2821804-13-9

PROTAC VHL-type degrader-1

CAS No.2821804-13-9
MDL No.N/A
MFC49H55N9O6S
MW898.10
InChI KeyJMKJBGWUGVQXJT-SVJXQAPASA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.2821804-13-9
Product NamePROTAC VHL-type degrader-1
Heavy Atom Count65Rotatable Bond Count17
Atom Stereo Count3Bond Stereo Count0
HBA12HBD4
TPSA196.930 ŲCharge0
Exact Mass897.39960Complexity2857.81
pKa6.155XLogP4.731

Documentation

Similar Products

  • (S,R,S)-AHPC-amido-C5-acid

    CAS No.2162120-87-6

  • (2S,4R)-1-((S)-2-(6-Aminohexanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide hydrochloride

    CAS No.2170695-20-0

  • VH 032 amide-alkylC6-acid

    CAS No.2172819-75-7

  • Protac linker 5

    CAS No.2245697-83-8

  • (S,R,S)-AHPC-CO-C1-NH2 HCl

    CAS No.2361120-26-3

  • N-Acetyl-3-Methyl-L-Valyl-(4r)-4-Hydroxy-N-[4-(4-Methyl-1,3-Thiazol-5-Yl)benzyl]-L-Prolinamide

    CAS No.1448188-62-2

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact